Superworth

Tandem Diabetes Care price to book ratio TNDM

Market value divided by the book value of the company's net assets, since 2014.

Today, Oct 23, 2026
9.3×
10-year median
12.5×
Against its 10-year history
36th
percentile: 0 is its lowest day, 100 its highest
10-year range
3.0× to 114×
Peer median
3.4×

Tandem Diabetes Care's price to book ratio is 9.3× as of Oct 23, 2026.

That is below its ten-year median of 12.5×, close to the middle of its last ten years.

Over that time it ranged from 3.0× in Nov 2023 to 114× in Jul 2018.

The median for 10 medical instruments and supplies stocks of a similar size is 3.4×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far9.3×6.6×12.1×
202511.4×4.3×11.4×
202410.2×4.8×13.7×
20236.1×3.0×7.0×
20226.9×5.4×21.4×
202124.5×14.1×24.8×
202018.2×15.3×31.1×
201921.3×17.3×34.4×
201818.5×15.7×114×
201714.4×13.0×15.6×
201612.7×2.9×15.6×
20155.0×2.7×5.9×
20144.5×3.1×5.2×

Against its peers

Companies in Medical - Instruments & Supplies nearest Tandem Diabetes Care's size, closest first, today.

CompanyPrice to book ratio
TNDMTandem Diabetes Care9.3×
BVSBioventus5.5×
CDRECadre3.7×
STAAStaar Surgical3.1×
IRMDIradimed10.8×
EYENational Vision1.6×
LMATLemaitre Vascular4.6×
INSPInspire Medical Systems2.5×
MOVMovado1.4×
UFPTUFP Technologies5.0×
MDXGMimedx2.6×
Peer median3.4×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Tandem Diabetes Care

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.